Statins Saved My Father's Life. So Why Is He Still Getting Worse?
Statins Saved My Father's Life.
So Why Is He Still Getting Worse?
His LDL went from 180 to 72. His cardiologist was genuinely pleased. But his breathlessness was worse than before he started the statin. His kidney markers were creeping up. His energy had not returned. And nobody connected the dots. This story is not rare.
LDL controlled. Still exhausted. Still breathless.
This is the most common story in India's cardiology clinics. The statin is working — the number on the report looks good. But the patient is still getting worse. Not because the statin failed. Because LDL was never the whole story — and nobody told him that.
Statins save lives. That is not in dispute. But here is what most patients are never told: a statin addresses one of eleven upstream causes of heart disease. The other ten continue unchecked. And in Indian patients specifically — where fatty liver, elevated Lp(a), high cortisol, and insulin resistance are all simultaneously active — the ten causes that statins do not touch can continue doing serious damage even when LDL is perfectly controlled.
What Statins Cover vs What They Miss
Honest AssessmentSources: INTERHEART · Lancet SEA 2023 · AHA Cardio-Renal-Hepatic Axis 2024
What Statins Do — Precisely and Without Question
Statins inhibit HMG-CoA reductase, reducing LDL cholesterol production. They are among the most studied drugs in pharmaceutical history. Large meta-analyses show they reduce major cardiovascular events by 25 to 35% in high-risk patients. For patients who have already had a heart attack or have documented severe blockage — statins are essential. No Ayurvedic company should tell you to stop your statin.
What no one tells you is what the statin is not doing.
The Four Things Statins Were Never Designed to Address —
and Why They Matter in Indian Patients
The Liver — Where 80% of LDL Originates
Statins reduce LDL production in the liver. But they do not address why the liver became metabolically dysfunctional. If the underlying fatty liver disease or insulin resistance is not addressed, the liver's health continues declining — and the statin has to work harder to maintain LDL control. Some patients show rising liver enzymes on statins because the liver is already under stress. The root cause is advancing while the symptom is suppressed.
Lancet Regional Health SEA 2023The Kidneys — The Blood Pressure Feedback Loop
The AHA's Cardio-Renal-Hepatic Axis (2024) confirms what Charaka documented in 400 BCE: heart, liver, and kidneys function as a triad. When kidney filtration declines, blood pressure rises. When blood pressure rises chronically, arterial walls thicken and the heart works harder. The blockage may be reducing on statins while a kidney-driven BP spiral is simultaneously accelerating cardiovascular damage through a completely different pathway.
AHA Cardio-Renal-Hepatic Axis 2024Inflammation — The Fire Statins Do Not Fully Extinguish
Statins have some mild anti-inflammatory properties (the JUPITER trial showed rosuvastatin reduced hsCRP somewhat). But for Indian patients with elevated Lp(a), high cortisol, insulin resistance, or ongoing NAFLD, the inflammatory load continues despite LDL normalisation. The INTERHEART Study found that inflammatory and psychosocial factors accounted for a substantial portion of India's excess cardiovascular risk — none of which statins specifically target.
INTERHEART Study · PMC3028954Platelet Aggregation — the Actual Final Trigger of a Heart Attack
A heart attack does not occur when plaque forms. It occurs when vulnerable plaque ruptures and a blood clot forms at the rupture site, blocking the artery. This final step is not addressed by statins. Clinical trial data shows Arjuna bark's arjunolic acid inhibits platelet aggregation more effectively than aspirin (IC50 0.048 mM vs aspirin's 0.088 mM). The drug that saved his life does not prevent the specific mechanism that would kill him again.
PlantChemSci / PMC4220499"When Arjuna bark powder was given along with statins for 3 months, it resulted in a 15% reduction in total cholesterol, 11% reduction in triglycerides, and 16% reduction in LDL — on top of what the statin alone achieved."
— Khalil, 2005 — 30 patients with documented coronary artery disease
LDL Production — One Pathway
30–50% LDL reduction. Some mild anti-inflammatory effect. Proven event reduction in high-risk patients. Essential for documented blockage or post-heart attack. Should not be stopped.
The 10 Pathways Statins Miss
Liver detoxification and repair. Kidney support. Inflammation reduction (hsCRP, IL-6). Platelet aggregation inhibition. Cardiac output improvement. Additional 16% LDL reduction on top of statin therapy (Khalil 2005).
The argument is not either/or. It is both/and.
Continue your statin. Add what it cannot do. Let the statin handle LDL. Let Clear Heaart handle liver health, inflammation, kidney support, and platelet aggregation. The Khalil 2005 study confirmed additive benefit — not interference. This is not a fight between two systems of medicine. It is using both intelligently.
Is your LDL controlled but you are still feeling worse?
This is more common than you think. Talk to our team — free WhatsApp consultation
Keep your statin. Add what it cannot do.
Clear Heaart is specifically designed to complement existing cardiac medication — addressing the liver, inflammation, kidneys, and platelet aggregation that statins were never built to address. The Khalil 2005 clinical trial confirmed the combination produces additive benefit.
India's First Ayurvedic Formula That Works at Every Stage of Heart Blockage
11 clinically-proven Ayurvedic ingredients addressing the 3 root causes — liver dysfunction, arterial inflammation, and platelet clotting — from Stage 1 through Stage 4.
Safe alongside your existing medication
Clear Heaart is safe to take alongside statins, beta-blockers, and antihypertensives. The Khalil 2005 study confirmed that Arjuna bark combined with statins produced additive benefit — not interference. Always inform your doctor when starting any new supplement.
See the Formula That Complements Your Existing Treatment
Clear Heaart is designed alongside — not instead of — your current medication. See which of the 11 ingredients addresses each of the four gaps your statin leaves open.
